Application of radiofrequency ablation in early stage non-small cell lung cancer: a multicenter, Phase III clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-TNC-10001208

Enrollment

Unknown

Registered

2010-12-22

Start date

2010-09-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

Case series:radiofreqency ablation

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with lung cancer without indication for resection; 2. Patients who are too old to tolerate the operation; 3. Patient who refuse surgery; 4. Lesion located at least 1 cm away from major vessels or airways.

Exclusion criteria

Exclusion criteria: 1. Performance status>2(ECOG); 2. Patients with medical comorbidities; 3. Uncontrolled coagulopathy with an international normalized ratio greater than 1.5 and platelet count is less than 106/mm3.

Design outcomes

Primary

Measure	Time frame
survival;	—

Secondary

Measure	Time frame
free disease survival;	—

Countries

China

Contacts

Public ContactBaodong Liu

ryouhoutou@yahoo.com.cn+86 10 83198646

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026